This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The University of Tokyo, Azabu Veterinary Medicine Educational Institution. Active years: 2015-2018.
Company Filing History:
4 out of 1,352 
2 out of 15 Years Active: 2015-2018
Title: Kunio Shiota: Innovator in Depression and Sleep Disorders
Introduction
Kunio Shiota is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of medicine and neuroscience, particularly in the treatment of depression and sleep disorders. With a total of 4 patents, his work has the potential to impact many lives.
Latest Patents
Shiota's latest patents include a depression treatment agent that contains N-acetyl-D-mannosamine. This invention provides a pharmaceutical composition for treating depression, which includes an effective amount of N-acetyl-D-mannosamine and a carrier acceptable as a medicament. Another notable patent involves methods for inducing orexin neurons and an agent for treating narcolepsy or eating disorders. This invention outlines a method for producing orexin neurons by culturing pluripotent stem cells or neural progenitor cells in the presence of N-acetyl-D-mannosamine, along with potential inhibitors. The therapeutic agent developed for narcolepsy or eating disorders, such as anorexia, is based on the induction of orexin neurons in vivo.
Career Highlights
Throughout his career, Kunio Shiota has worked with esteemed institutions, including the University of Tokyo and the Azabu Veterinary Medicine Educational Institution. His research has focused on innovative solutions to complex medical issues, showcasing his dedication to advancing healthcare.
Collaborations
Shiota has collaborated with notable colleagues, including Shintaro Yagi and Takefumi Kikusui. Their combined expertise has contributed to the development of groundbreaking treatments in their respective fields.
Conclusion
Kunio Shiota's innovative work in the treatment of depression and sleep disorders highlights his role as a leading inventor in the medical field. His patents reflect a commitment to improving mental health and overall well-being.